283 Brand S. Crohn’s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn’s disease. Gut (2009) 58(8):1152-67. Sands BE. Biomarkers of inflammation in inflammatory bowel disease. Gastroenterology (2015) 149(5):1275-85. Bourgonje AR, von Martels JZH, de Vos P, Faber KN, Dijkstra G. Increased fecal calprotectin levels in Crohn’s disease correlate with elevated serum Th1- and Th17- associated cytokines. PLoS One (2018) 13(2):e0193202. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl (1989) 170:2-6. Harvey RF, Bradshaw JM. A simple index of Crohn’s-disease activity. Lancet (1980) 1(8167):514. Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut (1998) 43(1):2932. Schoepfer AM, Beglinger C, Straumann A, Trummler M, Vavricka SR, Bruegger LE, et al. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn’s disease (SES-CD) than CRP, blood leukocytes, and the CDAI. Am J Gastroenterol (2010) 105(1):162-9. Rispo A, Testa A, De Palma GD, Donetto S, Diaferia M, Musto D, et al. Different profile of efficacy of thiopurines in Ulcerative Colitis and Crohn’s disease. Inflamm Bowel Dis (2015) 21(11):2570-5. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics (1988) 44(3):837-45. Davoine F, Lacy P. Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity. Front Immunol (2014) 5:570. Chen W, Paulus B, Shu D, Wilson, Chadwick V, et al. Increased serum levels of eotaxin in patients with inflammatory bowel disease. Scand J Gastroenterol (2001) 36(5):515-20. Mir A, Minquez M, Tatay J, Pascual I, Peña A, Sanchiz V, et al. Elevated serum eotaxin levels in patients with inflammatory bowel disease. Am J Gastroenterol (2002) 97(6):1452-7. Coburn LA, Horst SN, Chaturvedi R, Brown CT, Allaman MM, Scull BP, et al. High-throughput multi-analyte Luminex profiling implicates eotaxin-1 in ulcerative colitis. PLoS One (2013) 8(12):e82300. Korolkova OY, Myers JN, Pellom ST, Wang L, M’Koma AE. Characterization of serum cytokine profile in predominantly colonic inflammatory bowel disease to delineate ulcerative and Crohn’s colitides. Clin Med Insights Gastroenterol (2015) 8:29-44. Waddell A, Ahrens R, Steinbrecher K, Donovan B, Rothenberg ME, Munitz A, et al. Colonic eosinophilic inflammation in experimental colitis is mediated by Ly6C(high) CCR2(+) inflammatory monocyte/ macrophage-derived CCL11. J Immunol (2011) 186(10):5993-6003. Hogan SP, Mishra A, Brandt EB, Royalty MP, Pope SM, Zimmermann N, et al. A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. Nat Immunol (2001) 2:353-60. Saleh A, Shan L, Halayko AJ, Kung S, Gounni AS. Critical role for STAT3 in IL-17A-mediated CCL11 expression in human airway smooth muscle cells. J Immunol (2009) 182(6):3357-65. Rahman MS, Yamasaki A, Yang J, Shan L, Halayko AJ, Gounni AS. IL-17A induces eotaxin-1/CC chemokine ligand 11 in human airway smoothmuscle cells: role of MAPK (Erk1/2, JNK, and p38) pathways. J Immunol (2006) 177(6):4064-71. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med (1996) 2:449-56. Mishra A, Hogan SP, Lee JJ, Foster PS, Rothenberg ME. Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest (1999) 103:1719-27. 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 Predicting endoscopic disease activity in IBD
RkJQdWJsaXNoZXIy MjY0ODMw